Pablo Garrido

6PUBLICATIONS
21CO-AUTHORS
Molecular targetsGlycoconjugatesReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 27, 2026
Proadrenomedullin N-Terminal 20 Peptide (PAMP) Increases Proliferation and Induces Cytoskeleton Remodeling in Melanoma Cells Through the CXCR7/CXCR4/β-Arrestin Axis.

|Mar 28, 2026
Downregulation of the Long Non-Coding RNA MDL1AS Alters Metabolism, Differentiation, and Radiosensitivity in NTERA2 and SH-SY5Y Cells.

Adrián Casas-Benito, Pablo Garrido, Alfredo Martínez

|Jun 27, 2025
A DNA Vaccine Against Proadrenomedullin N-Terminal 20 Peptide (PAMP) Reduces Angiogenesis and Increases Lymphocyte and Macrophage Infiltration but Has No Effect on Tumor Burden in a Mouse Model of Lung Metastasis.

Tom Kalathil Raju, Srdan Tadic, Pablo Garrido

|Jan 26, 2024
Structure-Guided Approach for the Development of MUC1-Glycopeptide-Based Cancer Vaccines with Predictable Responses.

Iris A Bermejo, Ana Guerreiro, Ander Eguskiza

|Mar 16, 2022
Single Mutation on Trastuzumab Modulates the Stability of Antibody-Drug Conjugates Built Using Acetal-Based Linkers and Thiol-Maleimide Chemistry.

Xhenti Ferhati, Ester Jiménez-Moreno, Emily A Hoyt

|Oct 25, 2021
Bioorthogonal Self-Immolative Linker Based on Grob Fragmentation.

Xhenti Ferhati, Marina Salas-Cubero, Pablo Garrido

Pageof 1

Frequent Collaborators

6 joint publications

Alfredo Martínez

4 joint publications

Josune García-Sanmartín

3 joint publications

Gonçalo J L Bernardes

3 joint publications

Francisco Corzana